A new trading day began on Tuesday, with Niagen Bioscience Inc (NASDAQ: NAGE) stock price down -3.78% from the previous day of trading, before settling in for the closing price of $12.44. NAGE’s price has ranged from $2.40 to $14.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 25.10%. With a float of $49.81 million, this company’s outstanding shares have now reached $78.43 million.
Considering the fact that the conglomerate employs 104 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 62.51%, operating margin of 12.26%, and the pretax margin is 13.51%.
Niagen Bioscience Inc (NAGE) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Niagen Bioscience Inc is 36.77%, while institutional ownership is 31.93%. The most recent insider transaction that took place on Mar 07 ’25, was worth 2,146. In this transaction SVP, General Counsel of this company bought 273 shares at a rate of $7.86, taking the stock ownership to the 2,251 shares. Before that another transaction happened on Dec 13 ’24, when Company’s Director sold 37,161 for $6.19, making the entire transaction worth $229,956. This insider now owns 244,179 shares in total.
Niagen Bioscience Inc (NAGE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 25.10% per share during the next fiscal year.
Niagen Bioscience Inc (NASDAQ: NAGE) Trading Performance Indicators
Here are Niagen Bioscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.74. Likewise, its price to free cash flow for the trailing twelve months is 48.35.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.17, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.24 in one year’s time.
Technical Analysis of Niagen Bioscience Inc (NAGE)
Compared to the last year’s volume of 0.88 million, its volume of 1.2 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 11.30%.
During the past 100 days, Niagen Bioscience Inc’s (NAGE) raw stochastic average was set at 71.19%, which indicates a significant increase from 1.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.73 in the past 14 days, which was higher than the 0.52 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.31, while its 200-day Moving Average is $7.18. Nevertheless, the first resistance level for the watch stands at $12.37 in the near term. At $12.78, the stock is likely to face the second major resistance level. The third major resistance level sits at $12.99. If the price goes on to break the first support level at $11.75, it is likely to go to the next support level at $11.54. Should the price break the second support level, the third support level stands at $11.13.
Niagen Bioscience Inc (NASDAQ: NAGE) Key Stats
With a market capitalization of 942.87 million, the company has a total of 78,770K Shares Outstanding. Currently, annual sales are 99,600 K while annual income is 8,550 K. The company’s previous quarter sales were 30,480 K while its latest quarter income was 5,060 K.
